Thrombus Length Modifies Treatment Effect of Thrombolysis in Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial
Stroke: Vascular and Interventional Neurology · 20.11.2026
DOI: 10.1161/svin.126.002418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, online erschienen am 20.11.2026. Verfasst von Martin Arndt und 39 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: The benefit from intravenous thrombolysis (IVT) before endovascular therapy in patients with basilar artery occlusion is uncertain. We assessed whether thrombus length modifies the effect of IVT in patients from the BASICS trial (Basilar Artery International Cooperation Study). METHODS: BASICS was a multicenter randomized controlled trial comparing endovascular therapy plus best medical management versus medical management alone in basilar artery occlusion. We determined thrombus length on baseline computed tomography angiography and utilized receiver operating characteristic analysis to stratify cutoff values as additional covariates using regression modeling. We calculated adjusted odds ratios (aORs) for favorable outcome (modified Rankin Scale score 0–3 at 90 days) and performed interaction analyses. RESULTS: Among 300 BASICS patients, 282 had complete imaging data (median age, 69 [interquartile range, 60–76], National Institutes of Health Stroke Scale score, 22 [interquartile range, 11–35], IVT in 226 [80.1%], endovascular therapy in 145 [51.4%]). In multivariable analysis, thrombus length ≥7.5 mm (aOR, 0.51 [95% CI, 0.27–0.99]), age (odds ratio, 0.97 [95% CI, 0.95–1.00]), and National Institutes of Health Stroke Scale score (odds ratio, 0.91 [95% CI, 0.89–0.94]) were negatively, and IVT (odds ratio, 2.61 [95% CI, 1.07–6.37]) was positively associated with favorable outcome, whereas endovascular therapy was not (aOR, 1.27 [95% CI, 0.67–2.38]). Interaction analysis suggested increasing IVT benefit with longer thrombi (interaction odds ratio, 1.23; P =0.053). Although IVT showed no benefit with thrombi
Zitieren
APA
Arndt, M., Barlinn, K., Michel, P., Langezaal, L. C., Lima, F. O., Mont’alverne, F., Audebert, H. J., Gerber, J. C., Schoene, D., Zwam, W. H. V., Majoie, C. B., Huttner, H. B., Yoo, A. J., Schonewille, W. J., Puetz, V., Vos, J., Hoeven, E. V. D., Leersum, M. V., Heuvel, D. V. D., …, & Es, A. V. (2026). Thrombus Length Modifies Treatment Effect of Thrombolysis in Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial. Stroke: Vascular and Interventional Neurology. https://doi.org/10.1161/svin.126.002418
Vancouver
Arndt M, Barlinn K, Michel P, Langezaal LC, Lima FO, Mont’alverne F, et al. Thrombus Length Modifies Treatment Effect of Thrombolysis in Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial. Stroke: Vascular and Interventional Neurology. 2026. doi:10.1161/svin.126.002418
BibTeX
@article{Arndt2026,
author = {Arndt, Martin and Barlinn, Kristian and Michel, Patrik and Langezaal, Lucianne C.M. and Lima, Fabrício Oliveira and Mont’alverne, Francisco and Audebert, Heinrich J. and Gerber, Johannes C. and Schoene, Daniela and Zwam, Wim H. van and Majoie, Charles B.L.M. and Huttner, Hagen B. and Yoo, Albert J. and Schonewille, Wouter J. and Puetz, Volker and Vos, J.A. and Hoeven, E.J.R.J. van der and Leersum, M. van and Heuvel, D.A.F. van den and Strijen, M.J.L. van and Teunissen, L.L. and Dippel, D.W.J. and Lugt, A. van der and Es, A.C.G.M. van and Doormaal, P.J. van and Kappelle, L.J. and Lo, T.H. and Worp, H.B. van der and Boiten, J. and Nijeholt, G.J. Lycklama à and Nederkoorn, P.J. and Coutinho, J. and Emmer, B.J. and Staals, J. and Hofmeijer, J. and Martens, J. and Bernsen, M.L. and Wermer, M.J.H. and Walderveen, M.A.A. van and Es, A.C.G.M. van},
title = {Thrombus Length Modifies Treatment Effect of Thrombolysis in Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
doi = {10.1161/svin.126.002418}
}
EUVIMED